Article
Prognostic value of comprehensive typing based on m6A and gene cluster
2022-08-09
Abstract excerpt
<h4>Background: </h4> Triple-negative breast cancer (TNBC) is resistant to targeted therapy with HER2 monoclonal antibodies and endocrine therapy because it lacks the estrogen receptor (ER), progesterone receptor (PR), and human epidermal growth factor receptor 2 (HER2). TNBC is a subtype of breast cancer with the worst prognosis and the highest mortality rate compared to other subtypes. N6-methyladenosine (m6A) m...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 1698fdcb-2063-5345-9132-8e4c0ea23605
- DOI
- 10.21203/rs.3.rs-1922311/v1
